Source link : https://www.newshealth.biz/health-news/new-extended-release-parkinsons-drug-approved/
The FDA approved an oral extended-release formulation of levodopa and carbidopa known as IPX203 (Crexont) to treat Parkinson’s disease, Amneal Pharmaceuticals announced Wednesday. The treatment is a novel formulation that combines immediate-release granules of carbidopa and levodopa with extended-release pellets of levodopa. Its design means that therapeutic levels of levodopa and carbidopa may be maintained […]
Author : News Health
Publish date : 2024-08-08 19:50:55
Copyright for syndicated content belongs to the linked Source.